🕵️ Oruka Therapeutics, Inc. ($ORKA)
SEC insider & ownership activity, last 12 months · CIK 907654 · every row links its SEC filing
Over the last 12 months insiders sold $332.6M with no open-market buying against it. Fairmount Funds Management LLC sold $300.0M in discretionary trades (Jul). Harwin Peter Evan trimmed 20.0% → 19.5%; Fairmount Funds Management LLC trimmed 20.0% → 19.5%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 7 sellers, $332.6M (100 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 0 | – | 1 | $300.0M | Jul 1, 2026 |
| Dambkowski Carl | 0 | – | 5 | $8.6M | Jun 12, 2026 |
| Klein Lawrence Otto | 0 | – | 6 | $7.3M | Sep 15, 2026 |
| Paul T. Quinlan | 0 | – | 9 | $5.8M | Sep 15, 2026 |
| Goncalves Joana | 0 | – | 35 | $4.5M | Sep 15, 2026 |
| Agarwal Arjun | 0 | – | 25 | $4.3M | Sep 15, 2026 |
| Sandler Laura Lee | 0 | – | 19 | $1.9M | Sep 15, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Harwin Peter Evan | 19.5% | 13D | Jul 1, 2026 | filing ↗ | |
| Fairmount Funds Management LLC | 19.5% | 13D | Jul 1, 2026 | filing ↗ | |
| Kiselak Tomas | 19.5% | 13D | Jul 1, 2026 | filing ↗ | |
| Fairmount Healthcare Fund II L.P. | 16.0% | 13D | Jul 1, 2026 | filing ↗ | |
| Bong Y. Koh | 11.1% | 13G | Feb 27, 2025 | filing ↗ | |
| Venrock Healthcare Capital Partners III, L.P. | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| VHCP Co-Investment Holdings III, LLC | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners EG, L.P. | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| VHCP Management III, LLC | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| VHCP Management EG, LLC | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| Nimish Shah | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| Bong Y. Koh | 7.4% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 6.6% | 13G | Jan 21, 2026 | filing ↗ | |
| Capital World Investors | 5.6% | 13G | Aug 12, 2026 | filing ↗ | |
| David C. Ott | 5.5% | 13G | Sep 24, 2025 | filing ↗ | |
| RTW Investments, LP | 5.2% | 13G | Aug 14, 2026 | filing ↗ | |
| Roderick Wong | 5.2% | 13G | Aug 14, 2026 | filing ↗ | |
| Roderick WONG, M.D. | 5.2% | 13G | May 15, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Laura Sandler | $463K | Sep 1, 2026 | filing ↗ |
| Lawrence Klein | $6.9M | Sep 1, 2026 | filing ↗ |
| Paul Quinlan | $7.7M | Aug 14, 2026 | filing ↗ |
| Joana Goncalves | $1.8M | Jul 15, 2026 | filing ↗ |
| Arjun Agarwal | $2.5M | Jul 13, 2026 | filing ↗ |
| Fairmount Healthcare Fund II L.P. | $300.0M | Jul 1, 2026 | filing ↗ |
| Carl Dambkowski | $2.2M | Jun 11, 2026 | filing ↗ |
| Carl Dambkowski | $6.4M | May 21, 2026 | filing ↗ |
| Arjun Agarwal | $1.4M | May 18, 2026 | filing ↗ |
| Laura Sandler | $684K | May 1, 2026 | filing ↗ |
| Joana Goncalves | $1.4M | Apr 15, 2026 | filing ↗ |
| Laura Sandler | $546K | Jan 2, 2026 | filing ↗ |
| Joana Goncalves | $788K | Dec 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 24, 2026 | filing ↗ |
| Earnings (2.02) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 2, 2026 | filing ↗ |
| Other events (8.01) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Earnings (2.02) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 17, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 17, 2025 | filing ↗ |